Bioretec Welcomes Jordy Winters to Enhance Global Expansion

Strengthening Global Presence with Leadership Appointment
Bioretec Ltd, a leader in absorbable orthopedic implants, recently announced an exciting new addition to its leadership team. Jordy Winters has been appointed as the Vice President of Sales Outside U.S. (OUS) and will also be a key member of the Management Team. This strategic hire is aimed at propelling the company’s international commercial strategy and fostering growth in key markets around the globe.
Expertise That Drives Change
Bringing with him a wealth of experience, Winters has an impressive background in sales leadership from renowned companies such as Johnson & Johnson MedTech and Synthes. His track record of spearheading commercial adoption and building effective sales teams is commendable. Before joining Bioretec, he was the Spine Lead EMEA, where he skillfully orchestrated strategies that resulted in substantial regional growth.
Jordy has held several significant positions throughout his career, including Business Lead at DePuy Synthes and Sales Director in Orthopaedics. His passion for advancing orthopedics and spine care solutions has consistently contributed to better patient outcomes. With Winters now at the helm of global sales initiatives, Bioretec is gearing up for a remarkable expansion phase.
Leadership Vision for Future Growth
Sarah van Hellenberg Hubar-Fisher, CEO of Bioretec, expressed her enthusiasm about Winters' appointment, stating, "We are thrilled to welcome Jordy Winters to our executive team. His extensive experience in global orthopedic leadership is pivotal as we continue to enhance Bioretec's presence outside the U.S." This affirmation from leadership demonstrates a commitment to robust global expansion.
As Winters prepares to drive Bioretec’s international commercial success, he reflects on the company's positioning, saying, "Bioretec is entering a significant growth phase, meeting the rising demand for innovative and sustainable orthopedic solutions. I look forward to establishing strategic partnerships that will benefit patients, surgeons, and stakeholders globally."
A New Chapter for Global Medical Education
In addition to Winters' role, Rami Ojala, the previous Vice President of OUS Sales, will transition into a vital position as Head of Global Medical Education. Ojala's new focus will be to spearhead advancements in surgeon training programs, enhance educational initiatives, and facilitate clinical adoption of Bioretec's cutting-edge technologies across the world.
About Bioretec: Pioneering Orthopedic Innovation
Bioretec is a globally recognized Finnish medical device innovator specializing in transforming orthopedic care through unique, fully biodegradable implant technologies. The company prides itself on its pioneering approaches that improve the biological interface of active implants, leading to enhanced bone growth and quicker fracture healing after surgery. Bioretec's innovative solutions are utilized globally across approximately 40 countries.
The Activa product line from Bioretec features advanced bioabsorbable orthopedic implants crafted from a proprietary PLGA polymer. These implants ensure secure fixation through innovative techniques and naturally disintegrate over approximately two years, negating the need for complex removal surgeries while supporting optimal bone regeneration. Both CE marked and FDA cleared, the Activa line serves a wide array of indications for patients of all ages.
Additionally, the new RemeOs™ product line takes a step further by utilizing a high-performance magnesium alloy and hybrid composite, setting a new standard in absorbable materials for surgical applications. The RemeOs implants adeptly replace themselves with bone over time, eliminating the necessity for removal surgeries and promoting fracture healing. Bioretec has received authorization for its first RemeOs product in the U.S. and celebrated CE mark approval recently in Europe, signaling a promising future for orthopedic solutions.
Frequently Asked Questions
What role is Jordy Winters taking at Bioretec?
Jordy Winters has been appointed as Vice President of Sales Outside U.S. (OUS) and will help steer the company's international sales strategy.
What previous experience does Jordy Winters have?
Winters has extensive sales leadership experience from Johnson & Johnson MedTech and Synthes, with a focus on driving growth in orthopedic solutions.
What are Bioretec's key products?
Bioretec specializes in absorbable orthopedic implants, notably its Activa and RemeOs™ product lines, designed to enhance bone healing and reduce surgery needs.
What is the significance of Rami Ojala's new position?
Rami Ojala will lead Global Medical Education, focusing on improving surgeon training and advancing the adoption of Bioretec's innovative technologies.
How does Bioretec aim to impact global orthopedic care?
Bioretec is committed to providing innovative, sustainable orthopedic solutions that improve patient and surgical outcomes worldwide.
About The Author
Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.